Middle East & Africa Antimicrobial Resistance Diagnostics Market Size & Outlook
The antimicrobial resistance diagnostics market in Middle East & Africa is expected to reach a projected revenue of US$ 314.3 million by 2030. A compound annual growth rate of 6.4% is expected of Middle East & Africa antimicrobial resistance diagnostics market from 2022 to 2030.
Revenue, 2021 (US$M)
$179.5
Forecast, 2030 (US$M)
$314.3
CAGR, 2022 - 2030
6.4%
Report Coverage
Middle East & Africa
Middle East & Africa antimicrobial resistance diagnostics market, 2018-2030 (US$M)
Related Markets
MEA antimicrobial resistance diagnostics market highlights
- The MEA antimicrobial resistance diagnostics market generated a revenue of USD 179.5 million in 2021.
- The market is expected to grow at a CAGR of 6.4% from 2022 to 2030.
- In terms of segment, pcr was the largest revenue generating technology in 2021.
- Rapid & Point of Care is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2022 to 2030.
MEA data book summary
| Market revenue in 2021 | USD 179.5 million |
| Market revenue in 2030 | USD 314.3 million |
| Growth rate | 6.4% (CAGR from 2021 to 2030) |
| Largest segment | Pcr |
| Fastest growing segment | Rapid & Point of Care |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Microbiology Culture, Immunoassay, PCR, NGS, Mass Spectrometry, Rapid & Point of Care, Other Technology |
| Key market players worldwide | BioMerieux SA, Roche, Abbott Laboratories, Hologic Inc, BD, Danaher Corp, Accelerate Diagnostics Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.6% of the global antimicrobial resistance diagnostics market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,642.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antimicrobial Resistance Diagnostics Market Scope
Antimicrobial resistance diagnostics market segmentation & scope
Antimicrobial Resistance Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa antimicrobial resistance diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antimicrobial resistance diagnostics market will help companies and investors design strategic landscapes.
Pcr was the largest segment with a revenue share of 24.74% in 2021. Horizon Databook has segmented the Middle East & Africa antimicrobial resistance diagnostics market based on microbiology culture, immunoassay, pcr, ngs, mass spectrometry, rapid & point of care, other technology covering the revenue growth of each sub-segment from 2018 to 2030.
- Middle East & Africa Antimicrobial Resistance Diagnostics Technology Outlook (Revenue, USD Million, 2018-2030)
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Other Technology
- Middle East & Africa Antimicrobial Resistance Diagnostics Pathogen Outlook (Revenue, USD Million, 2018-2030)
- Drug Resistant Streptococcus Pneumoniae (DRSP)
- Drug Resistant Campylobacter (DRC)
- Clostridium Difficile (CD)
- Methicillin Resistant Staphylococcus Aureus (MRSA)
- Drug Resistant Neisseria Gonorrhoeae (DRNG)
- Drug Resistant Salmonella (DRNTS)
- Other Pathogen
- Middle East & Africa Antimicrobial Resistance Diagnostics End-user Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Other End-user
Reasons to subscribe to Middle East & Africa antimicrobial resistance diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa antimicrobial resistance diagnostics market databook
-
Our clientele includes a mix of antimicrobial resistance diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa antimicrobial resistance diagnostics market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa antimicrobial resistance diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA antimicrobial resistance diagnostics market report size, by country, 2018-2030 (US$M)
Middle East & Africa Antimicrobial Resistance Diagnostics Market Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
